Lemsip Cold & Flu Hot Lemon 500mg Powder for Oral Solution
- Name:
Lemsip Cold & Flu Hot Lemon 500mg Powder for Oral Solution
- Company:
Reckitt Benckiser Ireland Limited
- Active Ingredients:
- Legal Category:
Supply through general sale
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 15/01/20
(Click to Download) Summary of Product Characteristics last updated on medicines.ie: 29/11/2016
Print ViewKeyword Search SmPC
1. NAME OF THE MEDICINAL PRODUCT
1. NAME OF THE MEDICINAL PRODUCT
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
3. PHARMACEUTICAL FORM
3. PHARMACEUTICAL FORM
4. CLINICAL PARTICULARS
4. CLINICAL PARTICULARS
5. PHARMACOLOGICAL PROPERTIES
5. PHARMACOLOGICAL PROPERTIES
6. PHARMACEUTICAL PARTICULARS
6. PHARMACEUTICAL PARTICULARS
7. MARKETING AUTHORISATION HOLDER
7. MARKETING AUTHORISATION HOLDER
8. MARKETING AUTHORISATION NUMBER(S)
8. MARKETING AUTHORISATION NUMBER(S)
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
10. DATE OF REVISION OF THE TEXT
10. DATE OF REVISION OF THE TEXT
Reckitt Benckiser Ireland Limited
Company Products
Items Per Page :
1 - 0 of 64 items.Total: Infinity pages
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 15 January 2020 PIL
Reasons for updating
- Change to section 6 - manufacturer
Updated on 18 January 2017 PIL
Reasons for updating
- New PIL for new product
Updated on 18 January 2017 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 3 - how to take/use
- Change to section 4 - possible side effects
- Change to section 4 - how to report a side effect
- Change to section 5 - how to store or dispose
- Change to section 6 - what the product contains
Updated on 29 November 2016 SmPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.9 - Overdose
Legal category: Supply through general sale
Free text change information supplied by the pharmaceutical company
Section 4.4:
Deletion of warning "if symptoms persist, the physician should be consulted"
Addition of warning "if symptoms persist for more than seven days, please consult a healthcare professional"
Section 4.6:
Deletion of "For short term use in all trimesters of pregnancy. There is epidemiological evidence of safety in human pregnancy. Patients should follow the advice of their doctor regarding the use of paracetamol during pregnancy".
Addition of "A large amount of data on pregnancy women indicate neither malformative, nor feto/neonatal toxicity. paracetamol can be used during pregnancy If clinically needed however it should be used at the lowest effective dose for the shortest possible time and at the lowest possible frequency".
Section 4.9:
Addition of new data in relation to risk factors, symptoms and overdose management.
Deletion of warning "if symptoms persist, the physician should be consulted"
Addition of warning "if symptoms persist for more than seven days, please consult a healthcare professional"
Section 4.6:
Deletion of "For short term use in all trimesters of pregnancy. There is epidemiological evidence of safety in human pregnancy. Patients should follow the advice of their doctor regarding the use of paracetamol during pregnancy".
Addition of "A large amount of data on pregnancy women indicate neither malformative, nor feto/neonatal toxicity. paracetamol can be used during pregnancy If clinically needed however it should be used at the lowest effective dose for the shortest possible time and at the lowest possible frequency".
Section 4.9:
Addition of new data in relation to risk factors, symptoms and overdose management.
Updated on 29 November 2016 SmPC
Reasons for updating
- New SmPC for new product
Legal category: Supply through general sale
Updated on 10 August 2015 PIL
Reasons for updating
- Change to further information section
Updated on 30 January 2015 SmPC
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 6.1 - List of excipients
- Change to section 10 - Date of revision of the text
Legal category: Supply through general sale
Free text change information supplied by the pharmaceutical company
Section 2 - added Lactose to list of excipients
Section 4.4 - added warning regarding presence of Lactose
Section 6.1 - added to list of excipients: Lactose, polysorbate 80, and Silica
Section 10 - Changed date of revision of text to January 2014
Section 4.4 - added warning regarding presence of Lactose
Section 6.1 - added to list of excipients: Lactose, polysorbate 80, and Silica
Section 10 - Changed date of revision of text to January 2014
Updated on 30 March 2011 PIL
Reasons for updating
- New PIL for medicines.ie
Updated on 29 October 2009 SmPC
Reasons for updating
- Change to section 1 - Name of medicinal product
- Change to section 9 - Date of renewal of authorisation
Legal category: Supply through general sale
Free text change information supplied by the pharmaceutical company
Section 1: Strengh and form included in name
Section 9: change date of ast renewal
Section 9: change date of ast renewal
Updated on 15 May 2007 SmPC
Reasons for updating
- Change to marketing authorisation holder address
Legal category: Supply through general sale
Free text change information supplied by the pharmaceutical company
SECTION 7. Change of address of marketing authorisation holder to: 7 Riverwalk, Citywest Business Campus, Dublin 24, Ireland
Updated on 29 August 2006 SmPC
Reasons for updating
- Change to section 1 - Name of medicinal product
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 6.1 - List of excipients
- Change to section 6.4 - Special precautions for storage
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category: Supply through general sale
Free text change information supplied by the pharmaceutical company
Section 1: Trade Name - Should be Lemsip Cold & Flu Hot Lemon
Section 2: Qualitative and Quantitative Composition - Remove Ascorbic acid and Sodium citrate as actives
Section 4.4: Special Warnings and special precautions for use - Amount of carbohydrate in point 3 should be changed from 4.15g to 3g
Section 6.1 - List of excipients - Needs changing completely to : Sucrose, citric acid, Lemon flavour no.1, saccharin sodium, aspartame, sodium citrate, ascorbic acid and curcumin WD
Section 6.4 - Special precautions for storage - need to change 30°C to 25°C
Section 6.5 - Nature and contents of container - the words Surlyn laminate need changing to heat seal laminate
Section 10 - Date of (partial) Revision of the Text - should be April 2006
Updated on 19 May 2005 SmPC
Reasons for updating
- Improved electronic presentation
Legal category: Supply through general sale
Updated on 10 August 2004 SmPC
Reasons for updating
- Improved electronic presentation
Legal category: Supply through general sale
Updated on 16 June 2003 SmPC
Reasons for updating
- New SPC for medicines.ie
Legal category: Supply through general sale